SCP-6069
Thaumiel
~
medium confidence
SCP-6069
Expected annual
$6.3M
One-time setup
$2.3M
Annual recurring
$6.2M
Personnel
18
First‑year setup (one‑time) costs are dominated by containment cell & facility upgrades and specialized equipment; recurring annual costs are dominated by staff wages, overhead allocation, R&D and contingency reserves. Estimated one‑time ≈ $2.34M and recurring ≈ $6.21M/yr, with security, overhead and R&D as main drivers.
One-Time Capital Costs
Total: $2.3M
Annual Recurring Costs
Total: $6.2M/yr
Cost Scenarios
📊
Baseline
(baseline)
$6.2M/yr
Normal operational year with routine deployments and no major incidents.
routine_deployments
no_major_incident
scheduled_maintenance
🚨
Minor Incident
$6.4M/yr
Small containment or equipment incident requiring localized remediation, medical care and overtime.
small_release
minor_equipment_failure
limited_medical_care
🚨
Major Breach
$7.7M/yr
Significant containment failure or large remediation event with extended legal and medical costs.
containment_breach
large_scale_remediation
multi‑jurisdictional_response
🚨
Political Exposure
$8.7M/yr
Public/press exposure or cross‑jurisdictional political incident requiring heavy legal, PR and operational scaling.
public_incident
media_exposure
international_legal_actions
Personnel
18 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 8 | [#7] Continuous guard coverage (8 guards to cover 24/7 rotation) per analyst note. |
| Handler | 3 | [#7] Assigned handlers for interactions (3 handlers as specified). |
| Research Scientist / Analyst | 3 | [#13] Analysts for cataloguing and analysis (2–3 recommended; 3 used for budgeting). |
| Medical Officer | 2 | [#8] Medical and psychological staff (1–2 FTEs; 2 chosen to match allocated budget). |
| Emergency Responder / Specialist (on‑call) | 2 | [#18] Rapid response/on‑call specialists to support containment incidents (salaries included in staff_wages). |
Confidence Notes
Notes provide many explicit ranges and line items, allowing mid‑point estimation, but key uncertainties remain: deployment cadence, biosafety class required, frequency of adverse incidents, and insurer availability. Wide ranges on remediation/insurance/R&D drive medium confidence.